Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Monotherapy in Partial Seizures
NCT00524030Phase 3Terminated
- Sponsor
- Viatris
- Start
- Sep 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in focal seizures (2 arms), sponsored by Viatris. Primary endpoint: Percentage of Participants Discontinuing the Study Due to at Least 1 Pre-Defined Seizure Exit Criteria. Started Sep 2007; status: terminated.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00524030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524030.